Is my MS patient failing treatment?
From the Department of Medicine (H.B.), Melbourne Brain Centre at the Royal Melbourne Hospital, University of Melbourne, Australia; and Johns Hopkins Multiple Sclerosis Center (P.A.C.), Division of Neuroimmunology and Neuroinfectious Diseases, Baltimore, MD. butz@unimelb.edu.au.
Helmut
H
Butzkueven
From the Department of Medicine (H.B.), Melbourne Brain Centre at the Royal Melbourne Hospital, University of Melbourne, Australia; and Johns Hopkins Multiple Sclerosis Center (P.A.C.), Division of Neuroimmunology and Neuroinfectious Diseases, Baltimore, MD.
Peter A
PA
Calabresi
D018450:Disease Progression; D006801:Humans; D007155:Immunologic Factors / Q000494:pharmacology*; D016899:Interferon-beta / Q000494:pharmacology*; D009103:Multiple Sclerosis / Q000188:drug therapy*; D017211:Treatment Failure
D007155:Immunologic Factors; D016899:Interferon-beta